Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Lineage Cell Therapeutics (LCTX) R&D In Process (2018)

Historic R&D In Process for Lineage Cell Therapeutics (LCTX) over the last 1 years, with Q1 2018 value amounting to $800000.0.

  • Lineage Cell Therapeutics' R&D In Process changed N/A to $800000.0 in Q1 2018 from the same period last year, while for Dec 2018 it was $800000.0, marking a year-over-year change of. This contributed to the annual value of $800000.0 for FY2018, which is N/A changed from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported R&D In Process of $800000.0 as of Q1 2018.
  • In the past 5 years, Lineage Cell Therapeutics' R&D In Process registered a high of $800000.0 during Q1 2018, and its lowest value of $800000.0 during Q1 2018.